Skip to main content

Table 3 Summary of IC50-values

From: Analysis of the dose-dependent stage-specific in vitro efficacy of a multi-stage malaria vaccine candidate cocktail

SGM assay

Strain

P1

P50

3D7

IC50 [mg/ml]

Total IgG

>10.0

9.95

IC50 [mg/ml]

95 % CI

ND

7.625–12.98

IC50 [µg/ml]

PfCSP_TSR-specific

>4.47

11.92

IC50 [µg/ml]

95 % CI

ND

9.130–15.56

GIA

Strain

P1

P50

3D7A

7G8

V1-S

3D7A

7G8

V1-S

IC50 [mg/ml]

Total IgG

27.32

31.46

23.55

8.085

8.105

9.36

IC50 [mg/ml]

95 % CI

18.89–39.50

24.45–40.49

17.92–30.94

5.812–11.25

7.120–9.227

7.672–11.420

 

3D7

7G8

V1-S

3D7

7G8

V1-S

IC50 [µg/ml]

PfAMA1_DiCo mix specific

160.0

184.3

137.9

120.3

120.6

139.3

IC50 [µg/ml]

95 % CI

110.6–231.3

143.2–237.1

105.0–181.2

86.49–167.3

106.0–137.2

114.2–169.8

SMFA

Strain

P1

P50

NF54:HSP70:GFP:luc

IC50 [mg/ml]

Total IgG

0.7879

0.1427

IC50 [mg/ml]

95 % CI

0.434–1.43

0.09459–0.2153

IC50 [µg/ml]

Pfs25-specific

1.409

1.049

IC50 [µg/ml]

95 % CI

0.6935–2.862

0.6952–1.583